Tema Oncology ETF (CANC) Short Interest Ratio & Short Volume

Short interest is the volume of Tema Oncology ETF shares that have been sold short but have not yet been covered or closed out. As of January 31st, investors have sold 16,300 shares of CANC short. Learn More on Tema Oncology ETF's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CANC shares currently have a short interest ratio of 1.0. Learn More on Tema Oncology ETF's short interest ratio.

Tema Oncology ETF saw a increase in short interest during the month of January. As of January 31st, there was short interest totaling 16,300 shares, an increase of 232.7% from the previous total of 4,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies compare to Tema Oncology ETF: Fidelity Disruptive Communications ETF (0.18%), Procure Space ETF (0.26%), VictoryShares THB Mid Cap ESG ETF (0.07%), Global X Genomics & Biotechnology ETF (0.18%), Global X Aging Population ETF (0.05%), Tradr 2X Long Innovation ETF (11.97%), Tema Cardiovascular and Metabolics ETF (0.07%), Siren Nasdaq NexGen Economy ETF (0.18%), Spear Alpha ETF (4.11%), Tradr 2X Short Innovation Daily ETF (10.24%),

As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.21 billion), Charter Communications, Inc. ($4.07 billion), Reddit, Inc. ($3.33 billion), The Kroger Co. ($2.67 billion), Cencora, Inc. ($2.29 billion), Hims & Hers Health, Inc. ($2.17 billion), SoFi Technologies, Inc. ($1.99 billion), Live Nation Entertainment, Inc. ($1.87 billion), Rivian Automotive, Inc. ($1.76 billion), and Moderna, Inc. ($1.60 billion). View all of the most shorted stocks.

Short selling CANC is an investing strategy that aims to generate trading profit from Tema Oncology ETF as its price is falling. CANC shares are trading down $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Tema Oncology ETF occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CANC, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CANC, twice per month. The most recent reporting period available is January, 31 2025.